Olié E

Psychiatry, CHU Montpellier , ,

5 papers

ArticlePsilocybin

One dose of Psilocybin modulates Brain Activity among Depressive patients : Preliminary Neuroimaging Results from the PSILODAC Study

Pastre M, Pereira F, Gibert T +6

Europe PMC2026
ArticleKetamine

Patient reported outcomes of MDD patients treated with esketamine nasal spray in real world practice: the French ELLIPSE study

Llorca P, Samalin L, Olié E +4

Europe PMC2026
ArticleKetamine

Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).

Llorca PM, Sauvaget A, Olié E +12

Europe PMC2026
ArticleKetamine

Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.

Rothärmel M, Mekaoui L, Kazour F +21

Europe PMC2026
ArticlePsilocybin

Commentary: Psychedelic Psychiatry's Brave New World.

Nobile B, Olié E, Courtet P

Europe PMC2020